3RD BI RECALLS Flashcards
A 24-yo patient sought consultation because of 3-day duration of flu-like illness
characterized by mild sore throat, nasal catarrh, cough, body malaise and feeling
feverish. The physician may:
Prescribe oral paracetamol for fever
Advise to stay at home, take rest, and increase oral fluids
Test for COVID 19 infection
Prescribe oral acyclovir
- Prescribe oral paracetamol for fever
- Advise to stay at home, take rest, and increase oral fluids
- Test for COVID 19 infection
LAXATIVE AND MECHANISM OF ACTION:
- Emulsifies the fat component of stool
Mineral Oil
Psyllium
Ipecac
Docusate
Lactulose
Bisacodyl
Docusate
LAXATIVE AND MECHANISM OF ACTION:
- Draws water into the intestine
Mineral Oil
Psyllium
Ipecac
Docusate
Lactulose
Bisacodyl
Lactulose
LAXATIVE AND MECHANISM OF ACTION:
- Forms a slippery coat
Mineral Oil
Psyllium
Ipecac
Docusate
Lactulose
Bisacodyl
Mineral Oil
LAXATIVE AND MECHANISM OF ACTION:
- Stimulates the intestinal nerve plexuses
Mineral Oil
Psyllium
Ipecac
Docusate
Lactulose
Bisacodyl
Bisacodyl
First- line therapy for mild to moderate ulcerative colitis:
Sulfasalazine
Prenisone
Adalimumab
Methotrexate
Sulfasalazine
This anti-fungal agent is known to cause acute drug-induced interstitial nephritis:
Amphotericin B
Miconazole
Flucytosine
Terbinafine
Amphotericin B
An aminoglycoside that can be used to treat tuberculosis:
Netilmicin
Streptomycin
Tobramycin
Gentamicin
Streptomycin
A patient complaining of gnawing epigastric pain relieved by food intake underwent
EGD. Rapid Urease Test was positive. Definitive treatment for the patient’s condition
includes:
Pantoprazole
Aluminum hydroxide
Clarithromycin
Metronidazole
Pantoprazole
Clarithromycin
Metronidazole
A medical clerk prescribed Pirenzepine to a patient with abdominal pain. Patient
complained of dry mouth during follow-up. This adverse effect is most likely due to this
mechanism:
Cholinergic antagonism
Adrenergic agonism
Adrenergic antagonism
Cholinergic agonism
Cholinergic antagonism
PIRENZIPINE-M1 MUSCARINIC RECEPTOR ANTAGONISTS
This antifungal drug binds to the ergosterol of the fungal cell membrane to form cell
membrane pores:
Nystatin
Ketoconazole
Griseofulvin
Terbinafine
Nystatin
First-line drug against mycobacterium leprae infections:
Ethambutol
Dapsone
Pyrazinamide
Ofloxacin
Dapsone
This drug acts on the hypnozoites of P. vivax and P. ovale in the liver that cause relapse of symptoms on reactivation:
Pyrimethamine
Primaquine
Quinine
Chloroquine
Pyrimethamine
Primaquine
KASAMA din ang Tafenoquine
If the category I TB patient has already been treated for 4 months but has interrupted
his anti-TB regimen for 2 weeks, the case may be:
Considered as Lost to Follow Up
Allowed to continue treatment
Allowed to continue treatment only if repeat DSSM is negative
Labelled as Treatment Failure
Allowed to continue treatment
A patient developed rash, hives and itchiness after taking co-amoxiclav antibiotic for a
soft tissue infection. Physician decided to change the antibiotic to which of the following?
Clarithromycin
Clindamycin
Sultamicillin
Cephalexin
Clarithromycin
Clindamycin
???
A 25-yo pregnant woman contracted malaria. Which anti-malarial drug can be used?
Mefloquine
Primaquine
Artemisinin
Doxycycline
Mefloquine
Artemisinin
Characteristic findings of tumor lysis syndrome include:
Hyperuricemia
Hypercalcemia
Hyperphosphatemia
Hypokalemia
Hyperuricemia
Hyperphosphatemia
-hyperuricemia
-hyperphosphatemia–>hypocalcemia
-hyperkalemia
A 26-yo male newly diagnosed HIV patient may be started with a combination of which antiviral drugs:
Efavirenz
Lamiduvine
Zidovudine
Amantadine
Efavirenz
Lamiduvine
Zidovudine
While on anti-TB regimen, patient complained of persistent burning sensation in the feet. As the physician, you will prescribe/advise:
Discontinuation of anti-TB drugs
Celecoxib
Cetirizine
Pyridoxine (Vitamin B6)
Pyridoxine (Vitamin B6)
This TNF blocker may be effective for the treatment of moderate-severe and refractory inflammatory bowel disease:
Infliximab
Methotraxate
Cyclosporine
Azathioprine
Infliximab
ANTI-NEOPLASTIC DRUG AND MECHANISM OF ACTION
Imatinib
DNA Polymerase
Dihydrofolate Reductase Inhibitor
Protein-Tyrosine Kinase Inhibitor
Topoisomerase II Inhibitor
Selective Estrogen Receptor Modulator
Thymidylate Synthase Inhibitor
Aromatase Inhibitor
Protein-Tyrosine Kinase Inhibitor
ANTI-NEOPLASTIC DRUG AND MECHANISM OF ACTION
Tamoxifen
DNA Polymerase
Dihydrofolate Reductase Inhibitor
Protein-Tyrosine Kinase Inhibitor
Topoisomerase II Inhibitor
Selective Estrogen Receptor Modulator
Thymidylate Synthase Inhibitor
Aromatase Inhibitor
Selective Estrogen Receptor Modulator
ANTI-NEOPLASTIC DRUG AND MECHANISM OF ACTION
Daunorubicin
DNA Polymerase
Dihydrofolate Reductase Inhibitor
Protein-Tyrosine Kinase Inhibitor
Topoisomerase II Inhibitor
Selective Estrogen Receptor Modulator
Thymidylate Synthase Inhibitor
Aromatase Inhibitor
Topoisomerase II Inhibitor
ANTI-NEOPLASTIC DRUG AND MECHANISM OF ACTION
Anastrozole
DNA Polymerase
Dihydrofolate Reductase Inhibitor
Protein-Tyrosine Kinase Inhibitor
Topoisomerase II Inhibitor
Selective Estrogen Receptor Modulator
Thymidylate Synthase Inhibitor
Aromatase Inhibitor
Aromatase Inhibitor